Figure 7 illustrates the differences in HGF plasma levels (measurement 1) between patients with supratentorial tumors (Me = 557.74 pg/ml) and patients with tumors of the posterior fossa (Me = 325.00 pg/ml) and tumors in other locations (Me = 697.84 pg/ml). The gene discussed is HGF; the disease is neoplasm.